8247 Stock Overview Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Biosino Bio-Technology and Science Incorporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Biosino Bio-Technology and Science Incorporation Historical stock prices Current Share Price HK$0.62 52 Week High HK$1.38 52 Week Low HK$0.48 Beta -0.36 1 Month Change -20.51% 3 Month Change -8.82% 1 Year Change -28.74% 3 Year Change -66.30% 5 Year Change -68.21% Change since IPO -77.25%
Recent News & Updates See more updates
Less than half of directors are independent Dec 30
Biosino Bio-Technology and Science Incorporation's (HKG:8247) Business And Shares Still Trailing The Industry Oct 31
First half 2024 earnings released: CN¥0.091 loss per share (vs CN¥0.037 loss in 1H 2023) Aug 30
Biosino Bio-Technology and Science Incorporation to Report First Half, 2024 Results on Aug 29, 2024 Aug 16
Biosino Bio-Technology and Science Incorporation's (HKG:8247) 26% Dip In Price Shows Sentiment Is Matching Revenues Jun 27
Shareholders Will Probably Be Cautious Of Increasing Biosino Bio-Technology and Science Incorporation's (HKG:8247) CEO Compensation At The Moment Jun 21
Biosino Bio-Technology and Science Incorporation, Annual General Meeting, Jun 28, 2024 Jun 08
Biosino Bio-Technology and Science Incorporation (HKG:8247) Held Back By Insufficient Growth Even After Shares Climb 46% Apr 22
Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way? Apr 01
Full year 2023 earnings released: CN¥0.08 loss per share (vs CN¥0.056 profit in FY 2022) Mar 29
Biosino Bio-Technology and Science Incorporation to Report Fiscal Year 2023 Results on Mar 27, 2024 Mar 18
New major risk - Market cap size Feb 14
Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues Feb 08
Third quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.074 profit in 3Q 2022) Nov 16
Biosino Bio-Technology and Science Incorporation to Report Nine Months, 2023 Results on Nov 14, 2023 Nov 03
Investor sentiment improves as stock rises 50% Nov 02
New major risk - Share price stability Oct 30
Biosino Bio-Technology and Science Incorporation Announces Executive Changes Sep 27
New major risk - Financial position Aug 11
Second quarter 2023 earnings released: CN¥0.002 loss per share (vs CN¥0.008 profit in 2Q 2022) Aug 11
New minor risk - Share price stability Aug 01
Some Confidence Is Lacking In Biosino Bio-Technology and Science Incorporation (HKG:8247) As Shares Slide 38% Jul 31
Biosino Bio-Technology and Science Incorporation to Report First Half, 2023 Results on Aug 10, 2023 Jul 29
First quarter 2023 earnings released: CN¥0.04 loss per share (vs CN¥0.004 loss in 1Q 2022) May 13
Biosino Bio-Technology and Science Incorporation Announces Resignation of Ren Fujin as Non-Executive Director Feb 14
Investor sentiment deteriorates as stock falls 17% Feb 08
Investor sentiment improves as stock rises 21% Jan 25
Investor sentiment deteriorated over the past week Jan 10
Investor sentiment deteriorated over the past week Dec 20
Investor sentiment improved over the past week Dec 06
Third quarter 2022 earnings released Nov 20
Less than half of directors are independent Nov 16
Biosino Bio-Technology and Science Incorporation to Report Nine Months, 2023 Results on Nov 14, 2022 Nov 02
Second quarter 2022 earnings released Aug 15
Biosino Bio-Technology and Science Incorporation to Report First Half, 2022 Results on Aug 11, 2022 Jul 30
First quarter 2022 earnings released May 13
Less than half of directors are independent Apr 27
Biosino Bio-Technology and Science Incorporation, Annual General Meeting, May 27, 2022 Mar 29
Full year 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.019 profit in FY 2020) Mar 29
Full year 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.019 profit in FY 2020) Mar 29
Investor sentiment deteriorated over the past week Mar 16
Investor sentiment deteriorated over the past week Feb 07
Investor sentiment improved over the past week Jan 24
Non Executive Director Shuangzi Zeng has left the company Nov 29
Non Executive Director Shuangzi Zeng has left the company Nov 29
Non Executive Director Shuangzi Zeng has left the company Nov 29
Non Executive Director Shuangzi Zeng has left the company Nov 29
Non Executive Director Shuangzi Zeng has left the company Nov 29
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 28
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 27
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 26
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Non Executive Director Shuangzi Zeng has left the company Nov 25
Third quarter 2021 earnings released Nov 15
Investor sentiment improved over the past week Nov 01 Shareholder Returns 8247 HK Biotechs HK Market 7D -16.2% -0.1% 2.1% 1Y -28.7% -0.6% 23.7%
See full shareholder returns
Return vs Market: 8247 underperformed the Hong Kong Market which returned 23.7% over the past year.
Price Volatility Is 8247's price volatile compared to industry and market? 8247 volatility 8247 Average Weekly Movement 8.9% Biotechs Industry Average Movement 8.1% Market Average Movement 6.5% 10% most volatile stocks in HK Market 14.0% 10% least volatile stocks in HK Market 3.0%
Stable Share Price: 8247 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8247's weekly volatility (9%) has been stable over the past year.
About the Company Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. It offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. The company also provides medical and medical inspection services; produces and sells medical instruments; and researches and develops, sells, and distributes biological reagents and instruments.
Show more Biosino Bio-Technology and Science Incorporation Fundamentals Summary How do Biosino Bio-Technology and Science Incorporation's earnings and revenue compare to its market cap? 8247 fundamental statistics Market cap HK$89.72m Earnings (TTM ) -HK$20.63m Revenue (TTM ) HK$301.58m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 8247 income statement (TTM ) Revenue CN¥283.76m Cost of Revenue CN¥164.54m Gross Profit CN¥119.22m Other Expenses CN¥138.63m Earnings -CN¥19.41m
Last Reported Earnings
Jun 30, 2024
Earnings per share (EPS) -0.13 Gross Margin 42.02% Net Profit Margin -6.84% Debt/Equity Ratio 66.3%
How did 8247 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/19 06:24 End of Day Share Price 2025/01/17 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Biosino Bio-Technology and Science Incorporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution T. J. Hsu KGI Securities Co. Ltd.
Show 0 more analysts 
